poisar

Stocks · News reference

This Adobe Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

BenzingaAvi Kapoor

Top analysts upgraded Palantir, Silicom, Adobe, and Chevron. See what other analysts think about these stocks. Photo via Shutterstock.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncResearchandmarkets.Com

    mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More

    The global mRNA therapeutics market (excluding COVID-19 applications) is projected to grow from USD 201 million in 2026 to USD 9.98 billion by 2035, with a 63% CAGR. Growth is driven by expanding oncology and rare disease pipelines, advances in lipid nanoparticle delivery, and strategic partnerships. However, challenges include tissue-selective delivery limitations, repeat-dose tolerability concerns, and regulatory complexities. Moderna and BioNTech dominate with approximately 70% of pipeline activity.

    Read original at globenewswire-inc
  2. The Motley FoolSelena Maranjian

    Got $10,000 to Invest in This High-Yield, Midstream Stock? Here's What It Could Be Worth in 10 Years.

    Hess Midstream LP (HESM) is highlighted as an attractive midstream energy investment opportunity, offering a 7.7% dividend yield with quarterly increases over nine years. The company operates oil, gas, and produced water handling assets in North Dakota's Bakken and Three Forks Shale plays. Its corporate structure was restructured in 2019 to simplify tax treatment for investors.

    Read original at the-motley-fool